ProCatid Medical

Company Overview

Snapshot

Founded in December 2006 by Uri Rosenschein, ProCatid Medical operates with 1–10 employees. In August 2019, the company entered into an asset purchase agreement with Cardiovascular Systems Inc. for the acquisition of certain assets and rights related to its WIRION system.

Business overview

ProCatid Medical develops embolic protection solutions within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics. Its core product, WIRION, is a distal embolic protection system featuring an independent filter unit that can be deployed on any commercially marketed guide wire. This system is designed for use in minimally invasive interventional procedures, including stenting in carotid, renal, lower limb, coronary, and SVG angioplasty, serving hospitals and doctors.

Strategic signal

In August 2019, ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc. for the acquisition of certain assets and rights related to its WIRION system. This transaction signals a strategic validation of ProCatid Medical's technology and its potential for broader market integration through established medical device companies, indicating a significant step in the commercialization and reach of its embolic protection solutions.

Company Intelligence Q&A

What is ProCatid Medical's primary product?

ProCatid Medical's primary product is WIRION, a distal embolic protection system designed for use in minimally invasive interventional procedures.

When was ProCatid Medical founded?

ProCatid Medical was founded in December 2006.

What was a significant corporate development for ProCatid Medical in 2019?

In August 2019, ProCatid Medical entered into an asset purchase agreement with Cardiovascular Systems Inc. for the acquisition of certain assets and rights related to its WIRION system.

What is the WIRION system designed to do?

The WIRION system is designed to provide embolic protection during stenting procedures, including carotid, renal, lower limb, coronary, and SVG angioplasty, by capturing emboli while maintaining continuous blood flow.

Which company acquired assets from ProCatid Medical?

Cardiovascular Systems Inc. acquired certain assets and rights related to the WIRION system from ProCatid Medical in August 2019.